Becotatug

• Target :

  EGFR

• Related Pathways :

  Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||Angiogenesis

• Purity :

  0.991

• Bioactivity :

  Becotatug (JMT101) is a humanised monoclonal antibody targeting EGFR, demonstrating antitumour activity when combined with Osimertinib for treating EGFR-mutated advanced NSCLC.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2648260-93-7